Display options
Cite
Maiese K. mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus. World J Diabetes. 2015;6(2):217-24doi: 10.4239/wjd.v6.i2.217.
Maiese, K. (2015). mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus. World journal of diabetes, 6(2), 217-24. https://doi.org/10.4239/wjd.v6.i2.217
Maiese, Kenneth. "mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus." World journal of diabetes vol. 6,2 (2015): 217-24. doi: https://doi.org/10.4239/wjd.v6.i2.217
Maiese K. mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus. World J Diabetes. 2015 Mar 15;6(2):217-24. doi: 10.4239/wjd.v6.i2.217. PMID: 25789103; PMCID: PMC4360415.
Copy Download .nbib Format: NLM
Share it on

World J Diabetes. 2015 Mar 15;6(2):217-24. doi: 10.4239/wjd.v6.i2.217.

mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.

World journal of diabetes

Kenneth Maiese

Affiliations

  1. Kenneth Maiese, Cellular and Molecular Signaling, Newark, NJ 07101, United States.

PMID: 25789103 PMCID: PMC4360415 DOI: 10.4239/wjd.v6.i2.217

Abstract

The World Health Organization estimates that diabetes mellitus (DM) will become the seventh leading cause of death during the next two decades. DM affects approximately 350 million individuals worldwide and additional millions that remain undiagnosed are estimated to suffer from the complications of DM. Although the complications of DM can be seen throughout the body, the nervous, cardiac, and vascular systems can be significantly affected and lead to disorders that include cognitive loss, stroke, atherosclerosis, cardiac failure, and endothelial stem cell impairment. At the cellular level, oxidative stress is a significant determinant of cell fate during DM and leads to endoplasmic reticulum stress, mitochondrial dysfunction, apoptosis, and autophagy. Multiple strategies are being developed to combat the complications of DM, but it is the mechanistic target of rapamycin (mTOR) that is gaining interest in drug development circles especially for protective therapies that involve cytokines and growth factors such as erythropoietin. The pathways of mTOR linked to mTOR complex 1, mTOR complex 2, AMP activated protein kinase, and the hamartin (tuberous sclerosis 1)/tuberin (tuberous sclerosis 2) complex can ultimately influence neuronal, cardiac, and vascular cell survival during oxidant stress in DM through a fine interplay between apoptosis and autophagy. Further understanding of these mTOR regulated pathways should foster novel strategies for the complications of DM that impact millions of individuals with death and disability.

Keywords: Apoptosis; Autophagy; Cardiac disease; Diabetes mellitus; Erythropoietin; Mechanistic target of rapamycin; Metformin; Neurodegeneration; Oxidative stress; Vascular disease

References

  1. Diabetes. 2011 Jun;60(6):1770-8 - PubMed
  2. Diabetes. 2012 Feb;61(2):272-80 - PubMed
  3. Endocr Res. 2011;36(3):116-23 - PubMed
  4. J Diabetes Res. 2013;2013:585897 - PubMed
  5. Histol Histopathol. 2005 Jan;20(1):299-315 - PubMed
  6. Vascul Pharmacol. 2012 Nov-Dec;57(5-6):139-49 - PubMed
  7. Cardiovasc Diabetol. 2012 Oct 15;11:129 - PubMed
  8. Cardiovasc Res. 2013 Mar 1;97(3):393-403 - PubMed
  9. Diabetes. 2015 Jan;64(1):36-48 - PubMed
  10. J Diabetes Res. 2013;2013:473575 - PubMed
  11. Aging (Albany NY). 2012 Jun;4(6):436-47 - PubMed
  12. Exp Gerontol. 2010 Mar;45(3):217-34 - PubMed
  13. Exp Diabetes Res. 2012;2012:836759 - PubMed
  14. Ageing Res Rev. 2013 Jan;12(1):103-15 - PubMed
  15. Curr Neurovasc Res. 2010 May;7(2):95-112 - PubMed
  16. Curr Neurovasc Res. 2007 Feb;4(1):63-71 - PubMed
  17. Ann Med. 2014 Dec;46(8):587-96 - PubMed
  18. Int J Mol Sci. 2012 Oct 26;13(11):13830-66 - PubMed
  19. Biochim Biophys Acta. 2010 Jul-Aug;1802(7-8):593-600 - PubMed
  20. J Neurochem. 2014 Jul;130(2):172-84 - PubMed
  21. Trends Mol Med. 2013 Jan;19(1):51-60 - PubMed
  22. Exp Cell Res. 2013 Aug 15;319(14 ):2296-306 - PubMed
  23. Diabetes Obes Metab. 2014 Sep;16 Suppl 1:4-15 - PubMed
  24. Curr Neurovasc Res. 2008 Aug;5(3):159-70 - PubMed
  25. Curr Neurovasc Res. 2012 May;9(2):91-101 - PubMed
  26. J Proteome Res. 2014 May 2;13(5):2433-44 - PubMed
  27. Mol Cell Endocrinol. 2010 Jun 10;321(2):194-206 - PubMed
  28. Aging Cell. 2014 Dec;13(6):1075-85 - PubMed
  29. Br J Pharmacol. 2014 Jun;171(11):2739-50 - PubMed
  30. PLoS One. 2013 Dec 09;8(12):e82287 - PubMed
  31. Curr Pharm Des. 2013;19(32):5663-77 - PubMed
  32. Diabetes. 2006 Apr;55(4):1022-8 - PubMed
  33. Nat Commun. 2014 Sep 26;5:4934 - PubMed
  34. Prog Neurobiol. 2008 Jun;85(2):194-213 - PubMed
  35. Diabetol Metab Syndr. 2014 Jul 28;6(1):80 - PubMed
  36. Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1198-206 - PubMed
  37. Curr Neurovasc Res. 2011 May;8(2):103-20 - PubMed
  38. Mol Cell. 2008 Apr 25;30(2):214-26 - PubMed
  39. Cell Signal. 2011 Aug;23 (8):1311-9 - PubMed
  40. Histol Histopathol. 2007 Nov;22(11):1251-67 - PubMed
  41. Curr Neurovasc Res. 2010 Feb;7(1):59-64 - PubMed
  42. DNA Cell Biol. 2013 Feb;32(2):41-9 - PubMed
  43. Exp Neurol. 2012 Jan;233(1):68-78 - PubMed
  44. Int J Mol Sci. 2012;13(9):11102-29 - PubMed
  45. Prog Neurobiol. 2012 Nov;99(2):128-48 - PubMed
  46. Wound Repair Regen. 2014 Jan-Feb;22(1):23-33 - PubMed
  47. Nature. 2012 Jan 18;481(7382):511-5 - PubMed
  48. Clin Chem Lab Med. 2011 Nov;49(11):1773-82 - PubMed
  49. Br J Pharmacol. 2014 Jan;171(2):523-35 - PubMed
  50. Acta Neuropathol Commun. 2014 Jul 08;2:71 - PubMed
  51. Mol Cell Biochem. 2014 Jan;385(1-2):125-32 - PubMed
  52. Behav Brain Res. 2013 Feb 1;238:44-7 - PubMed
  53. Biol Pharm Bull. 2014;37(7):1248-52 - PubMed
  54. Int J Mol Sci. 2014 Sep 22;15(9):16848-84 - PubMed
  55. Lab Anim Res. 2012 Jun;28(2):99-107 - PubMed
  56. Diabetologia. 2012 Nov;55(11):3128-40 - PubMed
  57. Clin Sci (Lond). 2009 Feb;116(3):191-203 - PubMed
  58. Genes Dev. 2008 Jan 15;22(2):239-51 - PubMed
  59. Curr Mol Med. 2014 Jan;14(1):3-21 - PubMed
  60. J Diabetes. 2015 Mar;7(2):231-9 - PubMed
  61. Curr Neurovasc Res. 2013 Feb;10(1):29-38 - PubMed
  62. J Agric Food Chem. 2012 Feb 1;60(4):1094-101 - PubMed
  63. Int J Biol Sci. 2014 Aug 23;10(8):921-39 - PubMed
  64. J Endocrinol. 2012 May;213(2):143-54 - PubMed
  65. Curr Med Chem. 2007;14(16):1729-38 - PubMed
  66. Diabetes. 2013 Apr;62(4):1270-81 - PubMed
  67. ScientificWorldJournal. 2009 Oct 02;9:1072-104 - PubMed
  68. J Clin Pharmacol. 2011 Feb;51(2):128-52 - PubMed
  69. Rev Endocr Metab Disord. 2014 Mar;15(1):79-97 - PubMed
  70. Cardiovasc Diabetol. 2011 Aug 10;10 :75 - PubMed
  71. Basic Res Cardiol. 2013 May;108(3):352 - PubMed
  72. Brain Behav Immun. 2014 Nov;42:157-68 - PubMed
  73. J Neurochem. 2011 Aug;118(4):460-74 - PubMed
  74. Redox Rep. 2004;9(2):111-6 - PubMed
  75. J Biol Chem. 2014 Feb 14;289(7):4145-60 - PubMed
  76. Neurobiol Dis. 2011 Jul;43(1):86-98 - PubMed
  77. J Neurosci. 2013 Aug 7;33(32):13138-49 - PubMed
  78. Br J Pharmacol. 2014 Jul;171(13):3146-57 - PubMed
  79. J Diabetes Res. 2014;2014:628591 - PubMed
  80. Int J Mol Sci. 2014 May 05;15(5):7667-83 - PubMed
  81. Diabetes. 2010 Oct;59(10):2426-34 - PubMed
  82. Sci Rep. 2014 Jul 01;4:5519 - PubMed
  83. Cardiovasc Diabetol. 2010 Sep 01;9:46 - PubMed
  84. Molecules. 2009 Sep 09;14(9):3446-85 - PubMed
  85. Neural Regen Res. 2014 Aug 1;9(15):1413-7 - PubMed
  86. Int J Mol Sci. 2014 Jun 10;15(6):10296-333 - PubMed
  87. PLoS One. 2014 Jul 11;9(7):e102013 - PubMed
  88. JAMA. 2005 Jan 5;293(1):90-5 - PubMed
  89. Cardiovasc Diabetol. 2014 Feb 12;13:42 - PubMed
  90. Antioxid Redox Signal. 2013 Apr 1;18(10 ):1141-53 - PubMed
  91. Neuroendocrinology. 2013;97(4):300-8 - PubMed
  92. Mol Cell Neurosci. 2011 Jun;47(2):145-53 - PubMed
  93. PLoS One. 2014 Jan 28;9(1):e86252 - PubMed
  94. FASEB J. 2015 Feb;29(2):589-96 - PubMed
  95. Cell Signal. 2012 Jan;24(1):17-24 - PubMed
  96. Am J Epidemiol. 2012 Jul 15;176(2):99-107 - PubMed
  97. Aging (Albany NY). 2012 Mar;4(3):187-201 - PubMed
  98. Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2123-34 - PubMed
  99. J Biol Chem. 2013 Aug 9;288(32):23194-202 - PubMed
  100. Expert Opin Drug Discov. 2013 Jan;8(1):35-48 - PubMed
  101. J Biol Chem. 2011 May 27;286(21):18465-73 - PubMed
  102. Age (Dordr). 2013 Oct;35(5):1531-44 - PubMed
  103. Exp Biol Med (Maywood). 2011 Sep;236(9):1051-63 - PubMed
  104. Peptides. 2013 Jan;39:71-9 - PubMed
  105. JAMA. 2006 Apr 12;295(14):1681-7 - PubMed
  106. Neurosci Lett. 2012 Dec 7;531(2):176-81 - PubMed
  107. Endocrinology. 2014 Apr;155(4):1207-21 - PubMed
  108. J Alzheimers Dis. 2012;29(1):89-98 - PubMed
  109. BMC Neurosci. 2012 Jan 19;13:11 - PubMed
  110. Bone. 2012 Feb;50(2):437-43 - PubMed
  111. Curr Neurovasc Res. 2011 Nov;8(4):270-85 - PubMed
  112. Arch Neurol. 2009 Mar;66(3):315-22 - PubMed
  113. Comp Biochem Physiol B Biochem Mol Biol. 2012 Sep;163(1):51-8 - PubMed
  114. Cardiovasc Diabetol. 2012 Jul 16;11:45 - PubMed
  115. Heart Fail Rev. 2014 Jan;19(1):113-21 - PubMed
  116. Expert Opin Ther Targets. 2012 Dec;16(12):1203-14 - PubMed
  117. Curr Neurovasc Res. 2007 Aug;4(3):194-204 - PubMed
  118. J Mol Endocrinol. 2014 Jan 09;52(1):67-76 - PubMed
  119. J Cell Biochem. 2012 Jan;113(1):220-8 - PubMed
  120. Int J Mol Med. 2012 Apr;29(4):613-8 - PubMed
  121. Rom J Morphol Embryol. 2011;52(4):1173-85 - PubMed
  122. Biomed Pharmacother. 2010 Dec;64(10):681-5 - PubMed
  123. PLoS One. 2012;7(9):e45456 - PubMed
  124. Curr Neurovasc Res. 2014 May;11(2):177-86 - PubMed
  125. Cell Biochem Funct. 2009 Oct;27(7):473-8 - PubMed
  126. Exp Mol Med. 2014 Aug 29;46:e111 - PubMed
  127. Diabetes. 1996 Apr;45(4):471-7 - PubMed

Publication Types